Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TT-01488 in Combination With Anti-CD20 Regimens for Mantle Cell Lymphoma
NCT07855016Phase 2Not yet recruiting
- Sponsor
- TransThera Biosciences
- Start
- Oct 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
A Phase 2 trial of TT-01488 in mantle cell lymphoma (MCL), sponsored by TransThera Biosciences. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
TT-01488
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT07855016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07855016.